HuGE Literature Finder
Records
1
-
4
CRISPR screens identify a novel combination treatment targeting BCL-X and WNT signaling for KRAS/BRAF-mutated colorectal cancers. Oncogene 2021 May 40 (18): 3287-3302. Jung Hae Rim, Oh Yumi, Na Deukchae, Min Seoyeon, Kang Jinjoo, Jang Dongjun, Shin Seungjae, Kim Jiwon, Lee Sang Eun, Jeong Eui Man, An Joon Yong, Sung Chang Ohk, Lee Won-Suk, Lee Charles, Cho Sung-Y |
Tumor suppressor miR-193a-3p enhances efficacy of BRAF/MEK inhibitors in BRAF-mutated colorectal cancer. Cancer science 2021 7 112 (9): 3856-3870. Hiraide Sakura, Takahashi Masanobu, Yoshida Yuya, Yamada Hideharu, Komine Keigo, Ishioka Chikas |
Correlation Between BCL2 and Mcl1 Single Nucleotide Polymorphisms and Chemotherapy Response in Jordanian Patients with Colorectal Cancer. Current pharmaceutical biotechnology 2020 Jul . Mhaidat Nizar M, Amawi Haneen, Alzoubi Karem |
A Novel Combination Treatment Targeting BCL-X and MCL1 for KRAS/BRAF-mutated and BCL2L1-amplified Colorectal Cancers. Molecular cancer therapeutics 2017 Jun . Cho Sung-Yup, Han Jee Yun, Na Deukchae, Kang Wonyoung, Lee Ahra, Kim Jooyoung, Lee Jieun, Min Seoyeon, Kang Jinjoo, Chae Jeesoo, Kim Jong-Il, Park Hansoo, Lee Won-Suk, Lee Charl |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 21, 2023
- Content source: